Vernier Mara E, Fick Meghan E, Johnson Tyler E, Ueda Yu, Vigani Alessio
Department of Small Animal Medicine and Surgery, University of Georgia, Athens, GA, United States.
Department of Clinical Science, North Carolina State University, Raleigh, NC, United States.
Front Vet Sci. 2024 Oct 22;11:1447629. doi: 10.3389/fvets.2024.1447629. eCollection 2024.
The objective of this case series is to describe the indications, methodology, and short-term outcomes of three cats with severe azotemia managed with pleural dialysis.
Three cats were presented separately to the emergency room (ER) on referral for severe azotemia of varying etiologies. Despite aggressive medical and/or surgical management, none of the cats showed improvement in their blood urea nitrogen (BUN) or creatinine values. Renal replacement therapy was recommended, but for varying reasons, the patients were unable to undergo a traditional extracorporeal method, such as intermittent hemodialysis (IDH). Instead, pleural dialysis was performed, and all three cats showed improvement in their renal values during and after their treatment. No significant complications were documented as a result of pleural dialysis. Two of the three cats were discharged from the hospital and the third cat was humanely euthanized due to poor prognosis.
Pleural dialysis is a novel therapeutic procedure that is not documented in veterinary or human literature. This method of renal replacement therapy was well-tolerated and had no reported complications. Careful case selection and risk-benefit analysis should be considered before attempting this procedure. Further studies are necessary to further define the utility of this therapeutic intervention, evaluate the incidence of complications, and determine long term outcomes following the procedure.
本病例系列的目的是描述三只患有严重氮质血症的猫接受胸膜透析治疗的适应证、方法和短期结果。
三只猫因不同病因导致的严重氮质血症分别被转诊至急诊室(ER)。尽管采取了积极的药物和/或手术治疗,但没有一只猫的血尿素氮(BUN)或肌酐值有所改善。建议进行肾脏替代治疗,但由于各种原因,这些患者无法接受传统的体外方法,如间歇性血液透析(IDH)。取而代之的是进行了胸膜透析,所有三只猫在治疗期间及治疗后肾脏指标均有所改善。胸膜透析未记录到明显并发症。三只猫中有两只出院,第三只猫因预后不良被实施安乐死。
胸膜透析是一种在兽医或人类文献中未被记载的新型治疗方法。这种肾脏替代治疗方法耐受性良好,且无并发症报告。在尝试该操作之前,应考虑仔细的病例选择和风险效益分析。需要进一步研究以进一步明确这种治疗干预的效用,评估并发症的发生率,并确定该操作后的长期结果。